Lytix Biopharma AS: Lytix Biopharma announces the publication of a paper describing how LTX-315 mediates antitumor activity through multiple pathways

Source :: European Union News. March 23, 2024
Publication Year :: 2024
Abstract: Oslo: Lytix Biopharma AS has issued the following news release: Lytix Biopharma ('Lytix') (Euronext Growth Oslo: LYTIX), a clinical stage immune-oncology company, today announces publication of a paper that describes [...]

Subjects :: Biological products industry
T cells
Dendritic cells
Business, international

Tools